Studying the Immunomodulatory Functions of PARP1 and PARP2 in Mouse Models of Cancer

Nura Lutfi1, Carlos Martínez2, José Yélamos3,4

  • 1Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

Insights

Poly(ADP-ribose) polymerases (PARP1 and PARP2) are crucial in DNA damage response and cancer therapy. New evidence shows PARP1 and PARP2 also modulate anti-tumor immunity, impacting cancer progression.

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Poly-ADP-ribosylation, mediated by PARP1 and PARP2, is central to the DNA damage response (DDR).
  • PARP inhibitors (PARPi) are established cancer therapeutics targeting DDR, primarily for their direct effects on tumor cells.
  • Emerging evidence highlights the immunomodulatory roles of PARP1 and PARP2, influencing the anti-tumor immune response and potentially affecting tumor progression.

Purpose of the Study:

  • To describe protocols for investigating the immunomodulatory functions of PARP1 and PARP2.
  • To provide methodologies for studying PARP1 and PARP2's impact on the tumor microenvironment and immune surveillance.
  • To facilitate research into the dual roles of PARP1/PARP2 in cancer therapy and immune response.

Main Methods:

  • Utilizing established mouse tumor models.
  • Implementing protocols to assess protein poly-ADP-ribosylation in response to DNA damage.
  • Developing assays to evaluate the impact of PARP1 and PARP2 on immune cell infiltration and function within tumors.

Main Results:

  • The described protocols enable the study of PARP1/PARP2-mediated immunomodulation in vivo.
  • These methods allow for the characterization of how PARP inhibition affects the tumor immune microenvironment.
  • The findings support the investigation of PARPi beyond their direct cytotoxic effects, considering their influence on anti-tumor immunity.

Conclusions:

  • PARP1 and PARP2 possess significant immunomodulatory functions relevant to cancer progression.
  • Understanding these immunomodulatory roles is crucial for optimizing PARPi-based cancer therapies.
  • The presented protocols offer a framework for dissecting the complex interplay between PARP enzymes, DNA damage response, and anti-tumor immunity.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K